Long-term risk of salvage cystectomy after radiotherapy for muscle- invasive bladder cancer

European Urology

Volumn 38, Issue 3, 2000, Pages 279-286

  Cooke, P W ^a,b,c   Dunn, J A ^b   Latief, T ^a   Bathers, S ^b   James, N D ^a,b   Wallace, D M A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c RUSSELLS HALL HOSPITAL   (United Kingdom)

Author keywords

Bladder cancer; Cisplatin; Radiotherapy; Salvage cystectomy; Surveillance

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; TRANSITIONAL CELL CARCINOMA;

EID: 0033848319     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020294     Document Type: Article

References (19)